scholarly journals Target: a Randomized, Phase Ii Trial Comparing Vintafolide Versus Vintafolide Plus Docetaxel, Versus Docetaxel Alone in Second-Line Treatment of Folate-Receptor-Positive Non-Small Cell Lung Cancer (Nsclc) Patients

2014 ◽  
Vol 25 ◽  
pp. v1 ◽  
Author(s):  
N. Hanna ◽  
E. Juhász ◽  
C. Cainap ◽  
O. Gladkov ◽  
R. Ramlau ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Folate Receptor ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Randomized Phase Ii ◽  
Nsclc Patients

A Randomized Phase II Trial of Oral Topotecan Versus Docetaxel in the Second-Line Treatment of Non–Small-Cell Lung Cancer

2008 ◽  
Vol 9 (3) ◽  
pp. 154-159 ◽  
Author(s):  
Suzanne Jones ◽  
Dana Thompson ◽  
John Barton ◽  
Jeff Patton ◽  
Dianna Shipley ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Randomized Phase Ii ◽  
Oral Topotecan

Phase II trial of prolonged infusion gemcitabine as second line treatment in non-small cell lung cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7316-7316
Author(s):  
M. B. Kleinman ◽  
I. Stewart ◽  
S. Ratmanskiy ◽  
M. Gayle ◽  
P. Bonomi
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Prolonged Infusion

Phase II trial of prolonged infusion gemcitabine as second line treatment in non-small cell lung cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7316-7316
Author(s):  
M. B. Kleinman ◽  
I. Stewart ◽  
S. Ratmanskiy ◽  
M. Gayle ◽  
P. Bonomi
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Prolonged Infusion
Sign in / Sign up

Export Citation Format

Share Document